drugset / Trial / NCT01437592
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial was conducted in Asia. The aim of this trial was to investigate the pharmacokinetic properties (the effect of the investigated drug on the body) of NN1250 (insulin degludec) in healthy Chinese subjects.
Timeline
- Start
- 2011-09-06
- Primary completion
- 2011-11-22
- Completion
- 2011-11-22
Publications
- Background Pei H, Jiang J, Bardtrum L, Haahr H. Pharmacokinetic properties of insulin degludec in healthy Chinese subjects. Diabetes Manag 2019;9(1):20-7
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin degludec | Protein / enzyme biologic | — | Subcutaneous |